IRIS Accounts Production v24.2.0.383 10469714 director 1.12.22 30.11.23 30.11.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure104697142022-11-30104697142023-11-30104697142022-12-012023-11-30104697142021-11-30104697142021-12-012022-11-30104697142022-11-3010469714ns16:EnglandWales2022-12-012023-11-3010469714ns15:PoundSterling2022-12-012023-11-3010469714ns11:Director12022-12-012023-11-3010469714ns11:PrivateLimitedCompanyLtd2022-12-012023-11-3010469714ns11:SmallEntities2022-12-012023-11-3010469714ns11:AuditExempt-NoAccountantsReport2022-12-012023-11-3010469714ns11:SmallCompaniesRegimeForDirectorsReport2022-12-012023-11-3010469714ns11:SmallCompaniesRegimeForAccounts2022-12-012023-11-3010469714ns11:FullAccounts2022-12-012023-11-301046971412022-12-012023-11-3010469714ns11:RegisteredOffice2022-12-012023-11-3010469714ns6:CurrentFinancialInstruments2023-11-3010469714ns6:CurrentFinancialInstruments2022-11-3010469714ns6:Non-currentFinancialInstruments2023-11-3010469714ns6:Non-currentFinancialInstruments2022-11-3010469714ns6:ShareCapital2023-11-3010469714ns6:ShareCapital2022-11-3010469714ns6:SharePremium2023-11-3010469714ns6:SharePremium2022-11-3010469714ns6:RetainedEarningsAccumulatedLosses2023-11-3010469714ns6:RetainedEarningsAccumulatedLosses2022-11-3010469714ns6:IntangibleAssetsOtherThanGoodwill2022-12-012023-11-3010469714ns6:PatentsTrademarksLicencesConcessionsSimilar2022-12-012023-11-3010469714ns6:PlantMachinery2022-12-012023-11-3010469714ns6:IntangibleAssetsOtherThanGoodwill2022-11-3010469714ns6:IntangibleAssetsOtherThanGoodwill2023-11-3010469714ns6:IntangibleAssetsOtherThanGoodwill2022-11-3010469714ns6:PlantMachinery2022-11-3010469714ns6:PlantMachinery2023-11-3010469714ns6:PlantMachinery2022-11-3010469714ns6:WithinOneYearns6:CurrentFinancialInstruments2023-11-3010469714ns6:WithinOneYearns6:CurrentFinancialInstruments2022-11-30
REGISTERED NUMBER: 10469714 (England and Wales)













Unaudited Financial Statements

for the Year Ended 30 November 2023

for

Carocell Bio Limited

Carocell Bio Limited (Registered number: 10469714)






Contents of the Financial Statements
for the Year Ended 30 November 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Carocell Bio Limited

Company Information
for the Year Ended 30 November 2023







DIRECTOR: Dr M Davies





REGISTERED OFFICE: London BioScience Innovation Centre
(LBIC)
2 Royal College Street
London
NW1 0NH





REGISTERED NUMBER: 10469714 (England and Wales)





ACCOUNTANTS: Nolan James Ltd
Chartered Accountants
Suite 1 Armcon Business Park
London Road South
Poynton
Stockport
Cheshire
SK12 1LQ

Carocell Bio Limited (Registered number: 10469714)

Balance Sheet
30 November 2023

30.11.23 30.11.22
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 13,957 17,048
Tangible assets 5 928 2,680
14,885 19,728

CURRENT ASSETS
Debtors 6 6,882 133,250
Cash at bank 6,930 74,111
13,812 207,361
CREDITORS
Amounts falling due within one year 7 8,960 19,042
NET CURRENT ASSETS 4,852 188,319
TOTAL ASSETS LESS CURRENT
LIABILITIES

19,737

208,047

CREDITORS
Amounts falling due after more than one
year

8

359,969

338,762
NET LIABILITIES (340,232 ) (130,715 )

CAPITAL AND RESERVES
Called up share capital 1,215 1,195
Share premium 744,262 666,519
Retained earnings (1,085,709 ) (798,429 )
SHAREHOLDERS' FUNDS (340,232 ) (130,715 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 November 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 November 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Carocell Bio Limited (Registered number: 10469714)

Balance Sheet - continued
30 November 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 29 August 2024 and were signed by:





Dr M Davies - Director


Carocell Bio Limited (Registered number: 10469714)

Notes to the Financial Statements
for the Year Ended 30 November 2023

1. STATUTORY INFORMATION

Carocell Bio Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents & licences are being amortised evenly over their estimated useful life of ten years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 33% on cost and 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 4 (2022 - 4 ) .

Carocell Bio Limited (Registered number: 10469714)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 December 2022
and 30 November 2023 30,903
AMORTISATION
At 1 December 2022 13,855
Charge for year 3,091
At 30 November 2023 16,946
NET BOOK VALUE
At 30 November 2023 13,957
At 30 November 2022 17,048

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 December 2022
and 30 November 2023 6,089
DEPRECIATION
At 1 December 2022 3,409
Charge for year 1,752
At 30 November 2023 5,161
NET BOOK VALUE
At 30 November 2023 928
At 30 November 2022 2,680

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Other debtors 6,882 133,250

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.23 30.11.22
£    £   
Bank loans and overdrafts 4,000 4,000
Trade creditors 207 -
Taxation and social security - 4,746
Other creditors 4,753 10,296
8,960 19,042

Carocell Bio Limited (Registered number: 10469714)

Notes to the Financial Statements - continued
for the Year Ended 30 November 2023

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.11.23 30.11.22
£    £   
Bank loans 6,000 10,000
Other creditors 353,969 328,762
359,969 338,762